Literature DB >> 4377709

B.C.G. suppression of pulmonary metastases from primary rat hepatomata.

R W Baldwin, M V Pimm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4377709      PMCID： PMC2009315          DOI： 10.1038/bjc.1974.223

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  15 in total

1.  Radiation-killed BCG in the treatment of transplanted rat tumours.

Authors:  R W Baldwin; A J Cook; D G Hopper; M V Pimm
Journal:  Int J Cancer       Date:  1974-06-15       Impact factor: 7.396

2.  Accurate identification of experimental pulmonary metastases.

Authors:  H Wexler
Journal:  J Natl Cancer Inst       Date:  1966-04       Impact factor: 13.506

3.  Granulomatous hepatitis: a complication of B.C.G. immunotherapy.

Authors:  J S Hunt; M J Silverstein; F C Sparks; C M Haskell; Y H Pilch; D L Morton
Journal:  Lancet       Date:  1973-10-13       Impact factor: 79.321

4.  Protective effects of delipidated mycobacterial cells and purified cell walls against Ehrlich carcinoma and a syngeneic lymphoid leukemia in mice.

Authors:  L Chedid; A Lamensans; F Parant; M Parant; A Adam; J F Petit; E Lederer
Journal:  Cancer Res       Date:  1973-09       Impact factor: 12.701

5.  BGG immunotherapy of local subcutaneous growths and post-surgical pulmonary metastases of a transplanted rat epithelioma of spontaneous origin.

Authors:  R W Baldwin; M V Pimm
Journal:  Int J Cancer       Date:  1973-09-15       Impact factor: 7.396

6.  Complications of BCG immunotherapy in patients with cancer.

Authors:  F C Sparks; M J Silverstein; J S Hunt; C M Haskell; Y H Pilch; D L Morton
Journal:  N Engl J Med       Date:  1973-10-18       Impact factor: 91.245

7.  Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.

Authors:  D L Morton; F R Eilber; W L Joseph; W C Wood; E Trahan; A S Ketcham
Journal:  Ann Surg       Date:  1970-10       Impact factor: 12.969

8.  BCG immunotherapy of a rat sarcoma.

Authors:  R W Baldwin; M V Pimm
Journal:  Br J Cancer       Date:  1973-10       Impact factor: 7.640

9.  Studies on the heterologous immunogenicity of a methanol-insoluble fraction of attenuated tubercle bacilli (BCG). II. Protection against tumor isografts.

Authors:  D W Weiss; R S Bonhag; P Leslie
Journal:  J Exp Med       Date:  1966-12-01       Impact factor: 14.307

10.  MODIFICATION OF CELL ANTIGENS DURING AMINOAZO DYE CARCINOGENESIS IN RAT LIVER.

Authors:  R W BALDWIN
Journal:  Br J Cancer       Date:  1964-06       Impact factor: 7.640
View more
  6 in total

Review 1.  Immunology of bronchial carcinoma.

Authors:  D A Evans
Journal:  Thorax       Date:  1976-10       Impact factor: 9.139

2.  Study of the effect of single or multiple doses of BCG on antibody-dependent cellular cytotoxicity.

Authors:  N Kiger; M Bruley-Rosset; R Huchet; G Mathe
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

Review 3.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

4.  Treatment of transplanted rat tumours with double-stranded RNA (BRL 5907). I. Influenced of systemic and local administration.

Authors:  M V Pimm; M J Embleton; R W Baldwin
Journal:  Br J Cancer       Date:  1976-02       Impact factor: 7.640

5.  Methanol extraction residue of BCG in the treatment of transplanted rat tumours.

Authors:  D G Hopper; M V Pimm; R W Baldwin
Journal:  Br J Cancer       Date:  1975-02       Impact factor: 7.640

6.  Effect of BCG on cell-mediated cytotoxicity and serum blocking factor during growth of rat hepatoma.

Authors:  M J Embleton
Journal:  Br J Cancer       Date:  1976-06       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.